Evidence mapPaperPMID 40329055Full record

ReviewDermatology and therapy2025

Bioactives for Estrogen-Deficient Skin: Topical and Oral Supplement Clinical Studies. A Narrative Review.

Edwin D Lephart

Abstract readReview
In one paragraph

Review in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Edwin D LephartDepartment of Cell Biology, Physiology and the Neuroscience Center, College of Life Sciences, Brigham Young University, Provo, UT, 84602, USA. Edwin_Lephart@byu.edu.ORCID http://orcid.org/0000-0003-2027-9187

Funding

Brigham Young University 19-2215
6 · The paper itself

Abstract

Bioactive compound applications by topical or oral administration have gained increased utilization/awareness in providing health benefits particularly due to changes in hormone levels and aging, especially in women with the decline and loss of estrogens. This narrative review focuses on the bioactive compounds such as the phytoestrogens that have estrogenic properties for improving skin health. Notably, phytoestrogens bind and/or activate estrogen beta receptors, which are abundant in skin layers to improve dermal health. This review presents: (a) skin characteristics with aging in women, (b) changes in hormone levels with aging in women (especially with estrogen deficiency), (c) the characteristics of phytoestrogens and other bioactive compounds, (d) topical and oral clinical studies of bioactive compounds (phytoestrogens) as antiaging treatment(s) for estrogen-deficient skin (during peri- and postmenopause), and (e) the advantages of treating the skin from the outside to inside by traditional topical therapies and treating the skin from the inside to the outside by nutraceutical supplementation, which represents a relatively new innovation of increasing popularity. While this is a growing area of research with promising results, more investigations are needed to understand the mechanism(s) of how combination ingredient formulations work to improve skin health and slow down the advancement of the aging process.

Indexed as

AgingDermalEstrogen receptorsMenopausePhytochemicalsPolyphenols

Identifiers

PMID40329055
PMCPMC12126418

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.